 Yeah, so in the last spate of approvals and meetings of advisors and both the CDC and the FDA, there are two main recommendations. The first was that the vaccine would be one type in the fall, and so not two types like we've had two times ago, and that it would be based on GN1. And like you said, Ariel, it would be recommended for those six months and over. And that's because...